3.8% CAGR of Global Contrast Media-Contrast Agents Market Report 2020

"Contrast media/contrast agents market is projected to grow at a CAGR of 3.8%."

ReportsnReports added a new report on The Global Contrast Media-Contrast Agents Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. In-depth study on the current state which focuses on the major drivers and restraints for the key players. Global Contrast Media-Contrast Agents Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts, geographic regions of the market and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Global Contrast Media-Contrast Agents Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=214059

Top Company Profiles in this Report-
Ge Healthcare
Bracco Imaging S.P.A
Bayer AG
Guerbet Group
Lantheus Medical Imaging, Inc.
Daiichi Sankyo
Unijules Life Sciences
J.B. Chemicals and Pharmaceuticals Ltd.
Sanochemia
Magnus Health
Taejoon Pharm
Jodas Expoim
Nano Therapeutics Pvt. Ltd.
Kiran X-Ray
Interpharma Praha A.S.

and more...

The global contrast media/contrast agents market is projected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide.

This report studies the Contrast Media/Contrast Agents market based on product, application, modality, indication, route of administration and region. The report also studies the different factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Growth in the market can primarily be attributed to factors such as the increasing number of approvals for contrast agents and the rising volume of CT and MRI examinations globally. The growing number of research & funding activities for contrast agents and their applications provide immense opportunities for players in the contrast media market.

Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

Based on the indication, the contrast media market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2019-2024. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the contrast media market in this region.

Break of primary participants was as mentioned below:

By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
By Designation: C-Level Executives: 43%, Directors:32%, Others: 25%
By Region: North America: 38%, Europe: 23%, Asia Pacific : 29%, RoW: 10%

GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany),Guerbet (France), Lantheus (US) were the leading players in the contrast media market.

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=214059

Key Benefits of Buying the Report

This report focuses on various levels of analysis--industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the Contrast Media/Contrast Agents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the contrast media market and garner greater market shares.

Table of Contents in this Report-

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary and Primary Research Methodology
2.1.1.1 Secondary Research
2.1.1.2 Primary Research
2.1.2 Key Insights From Primary Sources
2.1.3 Market Size Estimation Methodology
2.1.4 Revenue Mapping-Based Market Estimation
2.1.5 Market Data Validation and Triangulation
2.2 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Contrast Media: Market Overview
4.2 European Contrast Media Market, By Product (2019)
4.3 Contrast Media Market Share, By Product, 2019 vs. 2024
4.4 Contrast Media Market Share, By Route of Administration, 2019 vs. 2024
4.5 Contrast Media Market Share, By Indication, 2019 vs. 2024
4.6 Contrast Media Market Share, By Application, 2019 vs. 2024
4.7 Contrast Media Market Share, By Type, 2019 vs. 2024
4.8 Geographic Snapshot: Contrast Media Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cancer and Cvd
5.2.1.2 Approvals of Contrast Agents
5.2.1.3 Increasing Demand for Early Diagnosis and Rising Volume of CT and MRI Examinations
5.2.2 Restraints
5.2.2.1 Side-Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunities
5.2.3.1 Generic Contrast Media
5.2.3.2 Increasing Research
5.2.4 Challenges
5.2.4.1 Technological Advancements in Imaging Solutions
5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents

6 Contrast Media/Contrast Agents Market, By Type
6.1 Introduction
6.2 Iodinated Contrast Media
6.2.1 Iodinated Contrast Agents are Mostly Administered Via Injections for the Visualization of Body Organs & Tissues During an X-Ray Or Ct
6.3 Gadolinium-Based Contrast Media
6.3.1 APAC is the Fastest-Growing Market for Gadolinium-Based Contrast Media
6.4 Microbubble Contrast Media
6.4.1 Microbubble Contrast Media Segment to Register the Highest Growth Rate During the Forecast Period
6.5 Barium-Based Contrast Media
6.5.1 The Growth Rate of the Barium-Based Contrast Media Segment is Declining

7 Contrast Media/Contrast Agents Market, By Modality
7.1 Introduction
7.2 X-Ray/CT
7.2.1 X-Ray/CT Accounts for the Largest Share of the Contrast Media Market
7.3 Magnetic Resonance Imaging
7.3.1 Growing Number of MRI Scanners and Increasing MRI Examinations are Likely to Drive Market Growth
7.4 Ultrasound
7.4.1 Ultrasound Contrast Agents Will Register the Highest Growth Rate During the Forecast Period

8 Contrast Media/Contrast Agents Market, By Indication
8.1 Introduction
8.2 Cardiovascular Disorders
8.2.1 Cardiovascular Disorders Segment to Dominate the Contrast Media Market
8.3 Cancer
8.3.1 Asia Pacific is Expected to Register Relatively Higher Growth Owing to the High Cancer Prevalence in the Region
8.4 Gastrointestinal Disorders
8.4.1 Rising Prevalence of Gi Disorders to Support Market Growth
8.5 Musculoskeletal Disorders
8.5.1 Rising Incidence of Work-Related Musculoskeletal Disorders to Support Market Growth
8.6 Neurological Disorders
8.6.1 Rising Prevalence of Dementia Worldwide to Support Market Growth
8.7 Nephrological Disorders
8.7.1 Rising Prevalence of Esrd is Driving the Demand for Diagnostic Tools for Kidney Diseases

9 Contrast Media/Contrast Agents Market, By Route of Administration
9.1 Introduction
9.2 Intravascular Route
9.2.1 Intravascular Segment is Expected to Grow at the Highest CAGR During the Forecast Period
9.2.1.1 Intravenous (IV)
9.2.1.2 Intra-Arterial (IA)
9.3 Oral Route
9.3.1 North America to Dominate the Contrast Media Market for Oral Route of Administration
9.4 Rectal Route
9.4.1 Contrast Agents Administered Rectally are Liquid E-Z-Paque, Liquid Polibar Plus, and Micropaque
9.5 Other Routes of Administration

10 Contrast Media/Contrast Agents Market, By Application
10.1 Introduction
10.2 Radiology
10.2.1 Growing Number of Diagnostic Procedures to Drive the Contrast Media Market for Radiology Applications
10.3 Interventional Radiology
10.3.1 Increasing Popularity of Minimally Invasive Procedures to Support Market Growth
10.4 Interventional Cardiology
10.4.1 Rising Incidence of Cardiac Disorders to Drive the Demand for Interventional Cardiology Procedures

11 Contrast Media/Contrast Agents Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 The US Dominates the Global Contrast Media Market
11.2.2 Canada
11.2.2.1 Increasing Investments in Improving Medical Imaging--A Major Factor Driving Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Presence of Well-Developed Diagnostic Imaging Infrastructure is A Major Factor Supporting Market Growth in Germany
11.3.2 France
11.3.2.1 Increasing Prevalence of Cancer Will Drive the Market for Contrast Media in France
11.3.3 UK
11.3.3.1 Increasing Investments in the Field of Diagnostic Imaging to Boost Market Growth
11.3.4 Italy
11.3.4.1 Growing Prevalence of Cancer and Obesity Will Drive the Demand for Diagnostic Procedures in Italy
11.3.5 Spain
11.3.5.1 Shortage of Radiologists in the Country to Restrain Market Growth
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 Japan Dominates the APAC Contrast Media Market
11.4.2 China
11.4.2.1 High Incidence of Cancer and Strokes Will Support the Market for Contrast Media in China
11.4.3 India
11.4.3.1 Growing Investments in the Indian Radiology Market Will Propel Market Growth
11.4.4 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Right-To-Win
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
12.5 Competitive Scenario
12.5.1 Product Launches & Approvals
12.5.2 Expansions
12.5.3 Acquisitions
12.5.4 Partnerships and Collaborations

and more...

Contact us:
ReportsnReports
+ 1 888 391 5441
Email: sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.